{"id":2415,"date":"2022-10-24T14:40:10","date_gmt":"2022-10-24T12:40:10","guid":{"rendered":"http:\/\/grupo.us.es\/healthterritory\/?p=2415"},"modified":"2022-10-27T11:54:50","modified_gmt":"2022-10-27T09:54:50","slug":"assessment-of-impact-of-the-covid-19-pandemic-from-the-perspective-of-patients-with-rheumatic-and-musculoskeletal-diseases-in-europe-results-from-the-reumavid-study-phase-1","status":"publish","type":"post","link":"https:\/\/grupo.us.es\/healthterritory\/en\/assessment-of-impact-of-the-covid-19-pandemic-from-the-perspective-of-patients-with-rheumatic-and-musculoskeletal-diseases-in-europe-results-from-the-reumavid-study-phase-1\/","title":{"rendered":"Assessment of impact of the COVID-19 pandemic from the perspective of patients with rheumatic and musculoskeletal diseases in Europe: results from the REUMAVID study (phase 1)"},"content":{"rendered":"<h3>Assessment of impact of the COVID-19 pandemic from the perspective of patients with rheumatic and musculoskeletal diseases in Europe: results from the REUMAVID study (phase 1)<\/h3>\n<p>Marco Garrido-Cumbrera, Helena Marzo-Ortega, Laura Christen, Pedro Plazuelo-Ramos, Dale Webb, Clare Jacklin, Shantel Irwin, Laurent Grange, Souzi Makri, Elsa Fraz\u00e3o Mateus, Serena Mingolla, Katy Antonopoulou, Sergio Sanz-G\u00f3mez, Jos\u00e9 Correa-Fern\u00e1ndez, Loreto Carmona, Victoria Navarro-Comp\u00e1n<\/p>\n<p>RMD open. 2021<\/p>\n<h3><strong>Objective<\/strong><\/h3>\n<p>To assess the impact of the COVID-19 pandemic on patients with rheumatic and musculoskeletal diseases (RMDs).<\/p>\n<h3><strong>Methods<\/strong><\/h3>\n<p>REUMAVID is a cross-sectional study using an online survey developed by an international multidisciplinary patient-led collaboration across seven European countries targeting unselected patients with RMDs. Healthcare access, daily activities, disease activity and function, well-being (WHO Five Well-Being Index (WHO-5)), health status, anxiety\/depression (Hospital Anxiety and Depression Scale (HADS)) and access to information were evaluated. Data were collected in April-July 2020 (first phase).<\/p>\n<h3><strong>Results<\/strong><\/h3>\n<p>Data from the first phase included 1800 patients with 15 different RMDs (37.2% axial spondyloarthritis, 29.2% rheumatoid arthritis, 17.2% osteoarthritis and others). Mean age was 53, 80% female and 49% had undertaken university studies. During the beginning of the pandemic, 58.4% had their rheumatology appointment cancelled and 45.6% reported not having received any information relating to the possible impact of SARS-CoV-2 infection in their RMDs, with the main source being patient organisations (27.6%).Regarding habits, 24.6% increased smoking, 18.2% raised their alcohol consumption, and 45.6% were unable to continue exercising. Self-reported disease activity was high (5.3\u00b12.7) and 75.6% reported elevated pain. Half the patients (49.0%) reported poor well-being (WHO-5) and 46.6% that their health had changed for the worse during lockdown. According to HADS, 57.3% were at risk of anxiety and 45.9% of depression.<\/p>\n<h3><strong>Conclusion<\/strong><\/h3>\n<p>Throughout the first wave of the COVID-19 pandemic, patients with RMDs have experienced disruption in access to healthcare services, poor lifestyle habits and negative effects on their overall health, well-being and mental health. Furthermore, information on COVID-19 has not reached patients appropriately.<\/p>\n<h3>Link to the article<\/h3>\n<p><a href=\"https:\/\/rmdopen.bmj.com\/content\/7\/1\/e001546\">https:\/\/rmdopen.bmj.com\/content\/7\/1\/e001546<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Assessment of impact of the COVID-19 pandemic from the perspective of patients with rheumatic and musculoskeletal diseases in Europe: results from the REUMAVID study (phase 1) Marco Garrido-Cumbrera, Helena Marzo-Ortega, Laura Christen, Pedro Plazuelo-Ramos, Dale Webb, Clare Jacklin, Shantel Irwin, Laurent Grange, Souzi Makri, Elsa Fraz\u00e3o Mateus, Serena Mingolla, Katy Antonopoulou, Sergio Sanz-G\u00f3mez, Jos\u00e9 Correa-Fern\u00e1ndez,&hellip;<\/p>\n","protected":false},"author":7,"featured_media":2370,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[54],"tags":[],"class_list":["post-2415","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-articles","category-54","description-off"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.1.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Assessment of impact of the COVID-19 pandemic from the perspective of patients with rheumatic and musculoskeletal diseases in Europe: results from the REUMAVID study (phase 1) - Health &amp; Territory Research<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/grupo.us.es\/healthterritory\/en\/assessment-of-impact-of-the-covid-19-pandemic-from-the-perspective-of-patients-with-rheumatic-and-musculoskeletal-diseases-in-europe-results-from-the-reumavid-study-phase-1\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Assessment of impact of the COVID-19 pandemic from the perspective of patients with rheumatic and musculoskeletal diseases in Europe: results from the REUMAVID study (phase 1) - Health &amp; Territory Research\" \/>\n<meta property=\"og:description\" content=\"Assessment of impact of the COVID-19 pandemic from the perspective of patients with rheumatic and musculoskeletal diseases in Europe: results from the REUMAVID study (phase 1) Marco Garrido-Cumbrera, Helena Marzo-Ortega, Laura Christen, Pedro Plazuelo-Ramos, Dale Webb, Clare Jacklin, Shantel Irwin, Laurent Grange, Souzi Makri, Elsa Fraz\u00e3o Mateus, Serena Mingolla, Katy Antonopoulou, Sergio Sanz-G\u00f3mez, Jos\u00e9 Correa-Fern\u00e1ndez,&hellip;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/grupo.us.es\/healthterritory\/en\/assessment-of-impact-of-the-covid-19-pandemic-from-the-perspective-of-patients-with-rheumatic-and-musculoskeletal-diseases-in-europe-results-from-the-reumavid-study-phase-1\/\" \/>\n<meta property=\"og:site_name\" content=\"Health &amp; Territory Research\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-24T12:40:10+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-10-27T09:54:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/grupo.us.es\/newthterritory\/wp-content\/uploads\/2022\/10\/reumavid-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1845\" \/>\n\t<meta property=\"og:image:height\" content=\"811\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Jos\u00e9 Correa Fern\u00e1ndez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Jos\u00e9 Correa Fern\u00e1ndez\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/grupo.us.es\/healthterritory\/en\/assessment-of-impact-of-the-covid-19-pandemic-from-the-perspective-of-patients-with-rheumatic-and-musculoskeletal-diseases-in-europe-results-from-the-reumavid-study-phase-1\/\",\"url\":\"https:\/\/grupo.us.es\/healthterritory\/en\/assessment-of-impact-of-the-covid-19-pandemic-from-the-perspective-of-patients-with-rheumatic-and-musculoskeletal-diseases-in-europe-results-from-the-reumavid-study-phase-1\/\",\"name\":\"Assessment of impact of the COVID-19 pandemic from the perspective of patients with rheumatic and musculoskeletal diseases in Europe: results from the REUMAVID study (phase 1) - Health &amp; Territory Research\",\"isPartOf\":{\"@id\":\"https:\/\/grupo.us.es\/healthterritory\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/grupo.us.es\/healthterritory\/en\/assessment-of-impact-of-the-covid-19-pandemic-from-the-perspective-of-patients-with-rheumatic-and-musculoskeletal-diseases-in-europe-results-from-the-reumavid-study-phase-1\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/grupo.us.es\/healthterritory\/en\/assessment-of-impact-of-the-covid-19-pandemic-from-the-perspective-of-patients-with-rheumatic-and-musculoskeletal-diseases-in-europe-results-from-the-reumavid-study-phase-1\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/grupo.us.es\/healthterritory\/wp-content\/uploads\/2022\/10\/reumavid-1.png\",\"datePublished\":\"2022-10-24T12:40:10+00:00\",\"dateModified\":\"2022-10-27T09:54:50+00:00\",\"author\":{\"@id\":\"https:\/\/grupo.us.es\/healthterritory\/#\/schema\/person\/6edfd257e38aaa36b2d51b61392dfb7b\"},\"breadcrumb\":{\"@id\":\"https:\/\/grupo.us.es\/healthterritory\/en\/assessment-of-impact-of-the-covid-19-pandemic-from-the-perspective-of-patients-with-rheumatic-and-musculoskeletal-diseases-in-europe-results-from-the-reumavid-study-phase-1\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/grupo.us.es\/healthterritory\/en\/assessment-of-impact-of-the-covid-19-pandemic-from-the-perspective-of-patients-with-rheumatic-and-musculoskeletal-diseases-in-europe-results-from-the-reumavid-study-phase-1\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/grupo.us.es\/healthterritory\/en\/assessment-of-impact-of-the-covid-19-pandemic-from-the-perspective-of-patients-with-rheumatic-and-musculoskeletal-diseases-in-europe-results-from-the-reumavid-study-phase-1\/#primaryimage\",\"url\":\"https:\/\/grupo.us.es\/healthterritory\/wp-content\/uploads\/2022\/10\/reumavid-1.png\",\"contentUrl\":\"https:\/\/grupo.us.es\/healthterritory\/wp-content\/uploads\/2022\/10\/reumavid-1.png\",\"width\":1845,\"height\":811},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/grupo.us.es\/healthterritory\/en\/assessment-of-impact-of-the-covid-19-pandemic-from-the-perspective-of-patients-with-rheumatic-and-musculoskeletal-diseases-in-europe-results-from-the-reumavid-study-phase-1\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/grupo.us.es\/newthterritory\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Assessment of impact of the COVID-19 pandemic from the perspective of patients with rheumatic and musculoskeletal diseases in Europe: results from the REUMAVID study (phase 1)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/grupo.us.es\/healthterritory\/#website\",\"url\":\"https:\/\/grupo.us.es\/healthterritory\/\",\"name\":\"Health &amp; Territory Research\",\"description\":\"Interdisciplinary Research Group of the University of Seville\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/grupo.us.es\/healthterritory\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/grupo.us.es\/healthterritory\/#\/schema\/person\/6edfd257e38aaa36b2d51b61392dfb7b\",\"name\":\"Jos\u00e9 Correa Fern\u00e1ndez\",\"sameAs\":[\"http:\/\/grupo.us.es\/healthterritory\/\"],\"url\":\"https:\/\/grupo.us.es\/healthterritory\/author\/pepe\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Assessment of impact of the COVID-19 pandemic from the perspective of patients with rheumatic and musculoskeletal diseases in Europe: results from the REUMAVID study (phase 1) - Health &amp; Territory Research","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/grupo.us.es\/healthterritory\/en\/assessment-of-impact-of-the-covid-19-pandemic-from-the-perspective-of-patients-with-rheumatic-and-musculoskeletal-diseases-in-europe-results-from-the-reumavid-study-phase-1\/","og_locale":"es_ES","og_type":"article","og_title":"Assessment of impact of the COVID-19 pandemic from the perspective of patients with rheumatic and musculoskeletal diseases in Europe: results from the REUMAVID study (phase 1) - Health &amp; Territory Research","og_description":"Assessment of impact of the COVID-19 pandemic from the perspective of patients with rheumatic and musculoskeletal diseases in Europe: results from the REUMAVID study (phase 1) Marco Garrido-Cumbrera, Helena Marzo-Ortega, Laura Christen, Pedro Plazuelo-Ramos, Dale Webb, Clare Jacklin, Shantel Irwin, Laurent Grange, Souzi Makri, Elsa Fraz\u00e3o Mateus, Serena Mingolla, Katy Antonopoulou, Sergio Sanz-G\u00f3mez, Jos\u00e9 Correa-Fern\u00e1ndez,&hellip;","og_url":"https:\/\/grupo.us.es\/healthterritory\/en\/assessment-of-impact-of-the-covid-19-pandemic-from-the-perspective-of-patients-with-rheumatic-and-musculoskeletal-diseases-in-europe-results-from-the-reumavid-study-phase-1\/","og_site_name":"Health &amp; Territory Research","article_published_time":"2022-10-24T12:40:10+00:00","article_modified_time":"2022-10-27T09:54:50+00:00","og_image":[{"width":1845,"height":811,"url":"https:\/\/grupo.us.es\/newthterritory\/wp-content\/uploads\/2022\/10\/reumavid-1.png","type":"image\/png"}],"author":"Jos\u00e9 Correa Fern\u00e1ndez","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Jos\u00e9 Correa Fern\u00e1ndez","Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/grupo.us.es\/healthterritory\/en\/assessment-of-impact-of-the-covid-19-pandemic-from-the-perspective-of-patients-with-rheumatic-and-musculoskeletal-diseases-in-europe-results-from-the-reumavid-study-phase-1\/","url":"https:\/\/grupo.us.es\/healthterritory\/en\/assessment-of-impact-of-the-covid-19-pandemic-from-the-perspective-of-patients-with-rheumatic-and-musculoskeletal-diseases-in-europe-results-from-the-reumavid-study-phase-1\/","name":"Assessment of impact of the COVID-19 pandemic from the perspective of patients with rheumatic and musculoskeletal diseases in Europe: results from the REUMAVID study (phase 1) - Health &amp; Territory Research","isPartOf":{"@id":"https:\/\/grupo.us.es\/healthterritory\/#website"},"primaryImageOfPage":{"@id":"https:\/\/grupo.us.es\/healthterritory\/en\/assessment-of-impact-of-the-covid-19-pandemic-from-the-perspective-of-patients-with-rheumatic-and-musculoskeletal-diseases-in-europe-results-from-the-reumavid-study-phase-1\/#primaryimage"},"image":{"@id":"https:\/\/grupo.us.es\/healthterritory\/en\/assessment-of-impact-of-the-covid-19-pandemic-from-the-perspective-of-patients-with-rheumatic-and-musculoskeletal-diseases-in-europe-results-from-the-reumavid-study-phase-1\/#primaryimage"},"thumbnailUrl":"https:\/\/grupo.us.es\/healthterritory\/wp-content\/uploads\/2022\/10\/reumavid-1.png","datePublished":"2022-10-24T12:40:10+00:00","dateModified":"2022-10-27T09:54:50+00:00","author":{"@id":"https:\/\/grupo.us.es\/healthterritory\/#\/schema\/person\/6edfd257e38aaa36b2d51b61392dfb7b"},"breadcrumb":{"@id":"https:\/\/grupo.us.es\/healthterritory\/en\/assessment-of-impact-of-the-covid-19-pandemic-from-the-perspective-of-patients-with-rheumatic-and-musculoskeletal-diseases-in-europe-results-from-the-reumavid-study-phase-1\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/grupo.us.es\/healthterritory\/en\/assessment-of-impact-of-the-covid-19-pandemic-from-the-perspective-of-patients-with-rheumatic-and-musculoskeletal-diseases-in-europe-results-from-the-reumavid-study-phase-1\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/grupo.us.es\/healthterritory\/en\/assessment-of-impact-of-the-covid-19-pandemic-from-the-perspective-of-patients-with-rheumatic-and-musculoskeletal-diseases-in-europe-results-from-the-reumavid-study-phase-1\/#primaryimage","url":"https:\/\/grupo.us.es\/healthterritory\/wp-content\/uploads\/2022\/10\/reumavid-1.png","contentUrl":"https:\/\/grupo.us.es\/healthterritory\/wp-content\/uploads\/2022\/10\/reumavid-1.png","width":1845,"height":811},{"@type":"BreadcrumbList","@id":"https:\/\/grupo.us.es\/healthterritory\/en\/assessment-of-impact-of-the-covid-19-pandemic-from-the-perspective-of-patients-with-rheumatic-and-musculoskeletal-diseases-in-europe-results-from-the-reumavid-study-phase-1\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/grupo.us.es\/newthterritory\/"},{"@type":"ListItem","position":2,"name":"Assessment of impact of the COVID-19 pandemic from the perspective of patients with rheumatic and musculoskeletal diseases in Europe: results from the REUMAVID study (phase 1)"}]},{"@type":"WebSite","@id":"https:\/\/grupo.us.es\/healthterritory\/#website","url":"https:\/\/grupo.us.es\/healthterritory\/","name":"Health &amp; Territory Research","description":"Interdisciplinary Research Group of the University of Seville","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/grupo.us.es\/healthterritory\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Person","@id":"https:\/\/grupo.us.es\/healthterritory\/#\/schema\/person\/6edfd257e38aaa36b2d51b61392dfb7b","name":"Jos\u00e9 Correa Fern\u00e1ndez","sameAs":["http:\/\/grupo.us.es\/healthterritory\/"],"url":"https:\/\/grupo.us.es\/healthterritory\/author\/pepe\/"}]}},"wps_subtitle":"","_links":{"self":[{"href":"https:\/\/grupo.us.es\/healthterritory\/wp-json\/wp\/v2\/posts\/2415","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/grupo.us.es\/healthterritory\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/grupo.us.es\/healthterritory\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/grupo.us.es\/healthterritory\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/grupo.us.es\/healthterritory\/wp-json\/wp\/v2\/comments?post=2415"}],"version-history":[{"count":1,"href":"https:\/\/grupo.us.es\/healthterritory\/wp-json\/wp\/v2\/posts\/2415\/revisions"}],"predecessor-version":[{"id":2416,"href":"https:\/\/grupo.us.es\/healthterritory\/wp-json\/wp\/v2\/posts\/2415\/revisions\/2416"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/grupo.us.es\/healthterritory\/wp-json\/wp\/v2\/media\/2370"}],"wp:attachment":[{"href":"https:\/\/grupo.us.es\/healthterritory\/wp-json\/wp\/v2\/media?parent=2415"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/grupo.us.es\/healthterritory\/wp-json\/wp\/v2\/categories?post=2415"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/grupo.us.es\/healthterritory\/wp-json\/wp\/v2\/tags?post=2415"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}